Founded 14 years ago by immunologist and entrepreneur Rabinder Buttar, Clintec International conducts clinical research for pharmaceutical companies worldwide. Much of its work is aimed at developing vaccinations against diseases such as swine flu, malaria and Aids. The Glasgow business also conducts clinical trials for drugs designed to fight rare diseases. Last year it raised £8m from Elephant Capital to fund expansion in India. Its growing presence in emerging markets such as Africa, the Middle East and Latin America has helped international sales to grow by 63% a year, from £4.3m in 2007 to £11.4m in 2009.
This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.